Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis

The coronavirus disease 2019 (COVID-19) pandemic has become a global health crisis. Considering the recent food and drug administration (FDA) approval of remdesivir as the first officially approved agent for COVID-19 treatment, we performed this systematic review and meta-analysis to evaluate the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Rezagholizadeh, Afra, Khiali, Sajad, Sarbakhsh, Parvin, Entezari-Maleki, Taher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859696/
https://www.ncbi.nlm.nih.gov/pubmed/33549577
http://dx.doi.org/10.1016/j.ejphar.2021.173926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859696/
https://www.ncbi.nlm.nih.gov/pubmed/33549577
http://dx.doi.org/10.1016/j.ejphar.2021.173926

Ejemplares similares